Search Login Register
Borderline Leprosy
Summary
57
relevant articles (1 outcomes,
5 trials/studies)
found for this Disease
Description:
A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.
Also Known As:
Leprosy, Borderline; Borderline Leprosies; Dimorphous Leprosies; Dimorphous Leprosy; Leprosies, Borderline Show All >>
Key Drugs and Agents for Borderline Leprosy
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Prednisone (Sone)
:
1 outcome in 1 result
:
FDA 118
Generic
-
Lepromin
:
1 study in 5 results
: IBA
-
Antibodies
:
1 study in 3 results
: IBA
-
Peroxynitrous Acid (Peroxynitrite)
:
1 study in 2 results
: IBA
-
Rifampin (Rifampicin)
:
1 study in 2 results
:
FDA 10
Generic
-
3-nitrotyrosine
:
1 study in 2 results
: IBA
-
Lipids
:
1 study in 1 result
: IBA
-
Adrenal Cortex Hormones (Corticosteroids)
:
1 study in 1 result
: IBA
-
anti-leprosy vaccine
:
1 study in 1 result
: IBA
-
Dapsone
:
8 results
:
FDA 3
Show All >>
Diseases Related to Borderline Leprosy
-
Lepromatous Leprosy
-
Neuritis (Polyneuritis)
-
Tuberculoid Leprosy
-
Leprosy (Hansen's Disease)
-
Erythema Nodosum
Show All >>
Key Therapies for Borderline Leprosy
Efficacy Chart >>
-
Immunotherapy
:
1 study in 2 results
-
Aftercare (After-Treatment)
:
2 results
-
Chemoprevention
:
1 result
-
Transplantation (Transplant Recipients)
:
1 result
-
Drug Therapy (Chemotherapy)
:
1 result
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.